Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that its partner, Biogen, shared compelling topline results from the Phase 2 CELIA study evaluating diranersen (IONIS-MAPTRx/BIIB080), an ...
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that its partner, Biogen, shared compelling topline results from the Phase 2 CELIA study evaluating diranersen (IONIS-MAPT Rx /BIIB080), an ...
Robust reductions in tau pathology were observed across all studied doses, with results generally consistent with those observed in the Phase 1b study 1 Pre-specified analyses of cognitive endpoints ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
CELIA did not meet its primary endpoint assessing dose response; based on the strength of the biomarker and efficacy data, Biogen plans to advance diranersen to registrational development Robust ...
Celia Imrie was undeniably – and deservedly – one of the standout stars of the 2026 Bafta TV Awards. So having the chance to speak to her on the night felt incredibly special. As I sat near the back ...
De camino a su luna de miel, el vehículo de una pareja se avería, obligándoles a refugiarse en un remoto Airbnb. Al caer la noche, tres desconocidos enmascarados los aterrorizan hasta el ama... Leer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results